ArticleScientific reports2025

Pharmacovigilance study of drug-induced eye movement disorder based on FDA adverse event reports from 2004 to 2024.

Si-Yuan Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.